Last year, around 80,000 people died from an opioid overdose. While that’s fewer than were dying annually a few years ago, UT Health San Antonio professor of pharmacology and psychiatry Charles France ...

Fintel reports that on July 22, 2025, TD Cowen initiated coverage of IDEAYA Biosciences (NasdaqGS:IDYA) with a Buy recommendation. Analyst Price Forecast Suggests 101.53% Upside As of July 16 ...

Spruce Biosciences (SPRB) announces a 1-for-75 reverse stock split effective Aug 4, 2025, to meet Nasdaq requirements.

Spruce Biosciences, Inc. (OTCQB: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological dis ...

About Xenetic Biosciences Xenetic Biosciences, Inc. is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers.

Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform Written by xenetic biosciences inc.

SAN DIEGO-- (BUSINESS WIRE)--Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, announced ...

IDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849), a Potential First-in-Class DLL3-TOP1 ADC ...